pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • Tag › antinuclear antibodies

    Sharpe’s syndrome: from basic anti-inflammatory therapy to genetically engineered biological drugs

    Редактор | 2023, Clinical case, Practical medicine part 21 №3. 2023 | 19 июня, 2023

    K.R. SHAPOREVA1, S.A. LAPSHINA1, E.V. SUKHORUKOVA2, A.R. GARAEVA1, R.Z.  ABDRAKIPOV2, D.I. ABDULGANIEVA1, 2  1Kazan State Medical University, Kazan 2Republic Clinical Hospital, Kazan  Contact details: Shaporeva K.R. — resident doctor of the Department of Hospital Therapy Address: 49 Butlerov St., Kazan, Russian Federation, 420012, tel.: +7-919-643-51-93, e-mail: karina_shaporeva@mail.ru This article presents a clinical case of a patient […]

    Tag: 2023, A.R. GARAEVA, antibodies to ribonucleoprotein, antimitochondrial antibodies, antinuclear antibodies, D.I. ABDULGANIEVA, E.V. SUKHORUKOVA, K.R. SHAPOREVA, mixed connective tissue disease, Practical medicine part 21 №3. 2023, R.Z. ABDRAKIPOV, rituximab, S.A. LAPSHINA, systemic lupus erythematosus
    Комментарии к записи Sharpe’s syndrome: from basic anti-inflammatory therapy to genetically engineered biological drugs отключены
    • rus Версия на русском языке


      usa English version site


      Find loupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©